While no mechanistic trials have specifically examined GLP‐1 RAs in HF, emerging data suggest potential benefits beyond weight reduction, possibly mediated by the widespread distribution of GLP‐1 receptors across multiple organ systems.9 This evidence concerns the gene GCG and hydrops fetalis.